Market Cap$14.61B
P/E9.39x
PEG Ratio1.22
Div yield—
Beta0.75
SOLV Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)14.42%
Price vs S&P 500 (4W)-2.09%
PEG Ratio1.22
VGM Score59.94
P/E Ratio (Annual)9.39x
SOLV Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.91 | $2.55 | +33.78%(+$0.64) | |
| Q1 2026 | $1.35 | $1.48 | +9.33%(+$0.13) | |
| Q4 2025 | $1.50 | $1.57 | +5.00%(+$0.07) | |
| Q3 2025 | $1.43 | $1.50 | +4.73%(+$0.07) | |
| Q2 2025 | $1.45 | $1.69 | +16.25%(+$0.24) |
SOLV Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.73
3.73
3.82
3.82
Industry Peers — Surgical & Medical Instruments(142)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
SOLVSolventum Corporation | C | C | B | 1.8x | — | 54.8% | 23.9% | $85.81 |
| SYKStryker Corporation | C | B | C | 4.4x | 11.8% | 65.3% | 21.3% | $294.66 |
| MMM3M Company | C | D | B | 3.4x | -5.0% | 39.4% | 18.4% | $164.75 |
| BSXBoston Scientific Corp. | C | B | C | 3.1x | 15.2% | 69.5% | 19.8% | $44.39 |
| BDXBecton, Dickinson and Co. | B | D | A | 2.5x | 6.3% | 46.7% | 9.6% | $191.75 |
| MDLNMedline Inc. Class A common stock | C | D | C | 1.6x | — | 26.2% | 6.0% | $35.96 |
| RMDResMed Inc. | C | C | B | 5.9x | 12.1% | 61.1% | 33.4% | $238.97 |
| DXCMDexCom, Inc. | C | B | B | 6.5x | 19.3% | 64.3% | 22.9% | $86.04 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | 8.5x | 7.4% | 36.8% | 20.4% | $384.02 |
| BAXBaxter International Inc. | B | D | B | 1.1x | -0.8% | 30.7% | -2.3% | $25.28 |
| PENPenumbra, Inc. | F | C | B | 8.4x | 20.2% | 67.8% | 12.4% | $320.86 |
About Solventum Corporation
Solventum is a diversified healthcare company providing innovative medical solutions across three core areas: wound care and surgical supplies, dental products, and health information systems. The company leverages material science, data science, and digital technologies to serve hospitals, dental practices, and healthcare providers. Solventum generates the majority of its revenue in the United States while maintaining a growing international presence.